{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T16:34:03Z","timestamp":1782146043776,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jfo.2022.01.006","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T09:23:49Z","timestamp":1652433829000},"page":"597-602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Central serous chorioretinopathy following the BNT162b2 mRNA vaccine"],"prefix":"10.1016","volume":"45","author":[{"given":"J.","family":"Hanhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Roditi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Wasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Barhoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zadok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Brosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2022.01.006_bib0125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajic.2021.12.019","article-title":"How many lives do COVID vaccines save? Evidence from Israel","volume":"50","author":"Arbel","year":"2022","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jfo.2022.01.006_bib0130","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa2114255","article-title":"Protection of BNT162b2 vaccine booster against COVID-19 in Israel","volume":"385","author":"Bar-On","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfo.2022.01.006_bib0135","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study","volume":"398","author":"Barda","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2022.01.006_bib0140","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1016\/j.vaccine.2021.05.085","article-title":"COVID-19 vaccine hesitancy: lessons from Israel","volume":"39","author":"Gurwitz","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.jfo.2022.01.006_bib0145","doi-asserted-by":"crossref","first-page":"100770","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jfo.2022.01.006_bib0150","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","article-title":"Central serous chorioretinopathy: update on pathophysiology and treatment","volume":"58","author":"Nicholson","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2022.01.006_bib0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0039-6257(02)00338-7","article-title":"Central serous chorioretinopathy and glucocorticoids","volume":"47","author":"Bouzas","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2022.01.006_bib0160","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/02713683.2019.1565891","article-title":"Investigating the hypothesis of stress system dysregulation as a risk factor for central serous chorioretinopathy: a literature mini-review","volume":"44","author":"Scarinci","year":"2019","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jfo.2022.01.006_bib0165","first-page":"4688764","article-title":"Pachychoroid spectrum disorder findings in patients with coronavirus disease 2019","volume":"2021","author":"Abrishami","year":"2021","journal-title":"Case Rep Ophthalmol Med"},{"key":"10.1016\/j.jfo.2022.01.006_bib0170","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4103\/ijo.IJO_403_21","article-title":"Retinal manifestations in patients following COVID-19 infection: a consecutive case series","volume":"69","author":"Goyal","year":"2021","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jfo.2022.01.006_bib0175","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jfo.2021.10.001","article-title":"Bilateral central serous chorioretinopathy post-COVID-19","volume":"44","author":"Mahjoub","year":"2021","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2022.01.006_bib0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12348-021-00244-4","article-title":"\u2019Old wine in a new bottle\u00a0\u2013\u00a0post COVID-19 infection, central serous chorioretinopathy and the steroids","volume":"11","author":"Sanjay","year":"2021","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.jfo.2022.01.006_bib0185","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.2147\/JMDH.S323582","article-title":"Ocular manifestations of post-acute COVID-19 syndrome, upper Egypt early report","volume":"14","author":"Tohamy","year":"2021","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.jfo.2022.01.006_bib0190","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00006982-200408000-00023","article-title":"Central serous chorioretinopathy associated with anthrax vaccination","volume":"24","author":"Foster","year":"2004","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2022.01.006_bib0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.oftal.2013.04.007","article-title":"Central serous chorioretinopathy of unusual etiology: a report of 2 cases","volume":"89","author":"Palacios","year":"2014","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.jfo.2022.01.006_bib0200","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/bjo.33.6.358","article-title":"The significance of ocular complications following vaccination","volume":"33","author":"Rosen","year":"1949","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2022.01.006_bib0205","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.clinthera.2021.01.014","article-title":"The COVID-19 mRNA vaccines and the pandemic: do they represent the beginning of the end or the end of the beginning?","volume":"43","author":"Jhaveri","year":"2021","journal-title":"Clin Ther"},{"key":"10.1016\/j.jfo.2022.01.006_bib0210","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jfo.2021.11.003","article-title":"Central serous chorioretinopathy following Pfizer-BioNTech COVID-19 vaccine: a case report","volume":"45","author":"Delbarre","year":"2022","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2022.01.006_bib0215","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/kjm2.12473","article-title":"Disc edema in one eye and central serous chorioretinopathy in the other eye shortly after AstraZeneca COVID-19 vaccination","volume":"38","author":"Lee","year":"2022","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jfo.2022.01.006_bib0220","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ophtha.2005.01.003","article-title":"Fundus autofluorescence and central serous chorioretinopathy","volume":"112","author":"Spaide","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2022.01.006_bib0225","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1600-0420.2005.00582.x","article-title":"Clinical characteristics of subretinal deposits in central serous chorioretinopathy","volume":"83","author":"Wang","year":"2005","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jfo.2022.01.006_bib0230","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1167\/iovs.16-20351","article-title":"High-resolution imaging of intraretinal structures in active and resolved central serous chorioretinopathy","volume":"58","author":"Vogel","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2022.01.006_bib0235","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1097\/IAE.0000000000003277","article-title":"Uveitis after the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association","volume":"41","author":"Rabinovitch","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.jfo.2022.01.006_bib0240","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.3390\/jcm10245960","article-title":"Uveitis and other ocular complications following COVID-19 vaccination","volume":"10","author":"Bolletta","year":"2021","journal-title":"J Clin Med"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551222001346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551222001346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:18:04Z","timestamp":1759259884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551222001346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S0181551222001346"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2022.01.006","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central serous chorioretinopathy following the BNT162b2 mRNA vaccine","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2022.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}